TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2025
Back to search
Official data from USPTO
MILTENYI BIOMEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079305056Class
1, 5, 10, 16, 39, 42, 44
Filing
79305056
Registration
6696088
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/20/2025
Trademark type
Combined
Nice classes
1, 5, 10, 16, 39, 42, 44
Filing date
07/13/2020
Registration date
04/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2022
Last transaction
07/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
PASSMAN,NICOLE A
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a triangle in violet with blue and violet circles above the wording "MILTENYI" in violet next to the term "BIOMEDICINE" in blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Holders and representatives
Holders
Miltenyi Biotec B.V. & Co. KG
Representatives
Peter S. Sloane Leason Ellis LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 16Class 39Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
industrial chemicalsbiological preparations for use in cell culturesother than for medical or veterinary purposesbiochemical preparations for scientific purposes; acetone for use in separation process for biological materials; reagents for cell separationlabeling reagentsreagentscell culture mediasubstances and ingredients for the preparation of cell culture mediaall for commercial and scientific purposes and for the use in medical laboratories; reagents for the processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and counting of materialsespecially of chemical and biological material for scientific and research use; reagents with magnetic beads for scientific and research use; antibody reagents other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instrumentsespecially separation instrumentsanalysis instrumentsreactors and imaging instruments; reagents for processing of biological materialespecially tissuebone marrowcellsblood and its components other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; culture mediacell culture mediafreezing mediaall for scientific purposes; reagents for use in biotechnologyin biological treatment processes and in the biotechnology industry other than for medical or veterinary purposes
Class 5
veterinary preparations for treatment of cancerpharmaceutical preparations for the treatment of cancer; reagentscontrast mediamaterials and ingredients for the preparation of contrast mediaall for medical or veterinary purposes; reagents for the processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and counting of materialespecially of biological materialsreagents with magnetic beadsantibody reagentsall for medical or veterinary purposes; buffer solutions and reagents for use with medical instrumentsespecially separation instrumentsanalysis instrumentsreactor and imaging instruments; reagents for the processing of biological materialespecially tissuebone marrowcellsblood and its componentsall for medical or veterinary purposes; culture mediacell culture mediadiagnostic reagents and preparations for medical and veterinary purposes; freezing mediacontrast agentscontrast agents for in-vivo imagingall for medical and veterinary purposes; pharmaceutical productsespecially pharmaceutical products in the nature of cell cultures and pharmaceutical preparations for cellular therapy; chemicalbiological and biochemical preparations for therapeutic purposes for treatment of cancer; chemicalbiological and biochemical diagnostic preparations for medical purposes; diagnostic contrast agents for medical usecontrast agents for in-vivo imaging for medical use
Class 10
Apparatustubes for magnetic cell separation for medical purposes; tubing sets for cell separation for medical purposes; columns for magnetic cell separation for medical analysis cryogenic tubes and cryogenic freezing bags for medical purposesin particular for cryopreservation; dialysis machines for medical use; apheresis machines for medical use; veterinary apparatus and instrumentscentrifugation devices; medical apparatus and instrumentscentrifugation devices
Class 16
Plastic materials for packagingpackaging bags for the cryopreservation of biological and biochemical materialespecially cellular material for biological and medical research and therapy
Class 39
Biological and biochemical storageespecially cryopreserved material for medicalscientific and biotechnological purposes
Class 42
Scientific and technological servicesresearch and design of medical and laboratory equipment; industrial laboratory analysis and research services in the field of biology and medicine; design and development of computer hardware and software for the analysis of biological and biochemical material; all of the aforementioned services for and in connection with the analysis of biological and biochemical materialespecially of cellular material for biological and medical research and therapy
Class 44
Services of medicalpharmaceutical or biotechnological laboratoriesservices of a medical and pharmaceutical laboratoryin particular in connection with the manufacture of cell therapeutic agentscell compoundscell preparationcellular medicinesthe selectionstimulationactivation of cellsas well as the manufacture of kits or reagentsmedical servicesin particular the field of extracorporeal plasma therapy; medical treatment services
Publications
History of USPTO decisions and trademark events.
45 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/15/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/15/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/20/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/26/2022
FIMP
FINAL DISPOSITION PROCESSED
08/25/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/25/2022
PUBO
PUBLISHED FOR OPPOSITION
01/25/2022
DOCK
ASSIGNED TO EXAMINER
01/24/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/22/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/05/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/22/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/21/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/21/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/21/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2021
ALIE
ASSIGNED TO LIE
12/16/2021
NREV
NOTICE OF REVIVAL - E-MAILED
12/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2021
PETG
PETITION TO REVIVE-GRANTED
12/14/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
12/14/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/22/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/22/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/22/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/22/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/22/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/22/2021
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
11/01/2021
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
11/01/2021
DOCK
ASSIGNED TO EXAMINER
10/29/2021
RFNT
REFUSAL PROCESSED BY IB
03/29/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/09/2021
RFRR
REFUSAL PROCESSED BY MPU
03/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/05/2021
CNRT
NON-FINAL ACTION WRITTEN
03/04/2021
DOCK
ASSIGNED TO EXAMINER
03/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/25/2021
Continuous trademark protection
Get notified about every new filing that threatens MILTENYI BIOMEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.